CL2014002706A1 - Formulaciones vesiculares que comprenden un fosfolipido y un agente tensoactivo y el uso en el tratamiento del dolor o movilidad reducida de una articulación. - Google Patents
Formulaciones vesiculares que comprenden un fosfolipido y un agente tensoactivo y el uso en el tratamiento del dolor o movilidad reducida de una articulación.Info
- Publication number
- CL2014002706A1 CL2014002706A1 CL2014002706A CL2014002706A CL2014002706A1 CL 2014002706 A1 CL2014002706 A1 CL 2014002706A1 CL 2014002706 A CL2014002706 A CL 2014002706A CL 2014002706 A CL2014002706 A CL 2014002706A CL 2014002706 A1 CL2014002706 A1 CL 2014002706A1
- Authority
- CL
- Chile
- Prior art keywords
- phospholipid
- pain
- joint
- treatment
- active agent
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003904 phospholipids Chemical class 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1206486.1A GB201206486D0 (en) | 2012-04-12 | 2012-04-12 | Vesicular formulations and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014002706A1 true CL2014002706A1 (es) | 2015-04-24 |
Family
ID=46208989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014002706A CL2014002706A1 (es) | 2012-04-12 | 2014-10-08 | Formulaciones vesiculares que comprenden un fosfolipido y un agente tensoactivo y el uso en el tratamiento del dolor o movilidad reducida de una articulación. |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20150065461A1 (enExample) |
| EP (1) | EP2836203B1 (enExample) |
| JP (1) | JP2015512926A (enExample) |
| KR (1) | KR102204725B1 (enExample) |
| CN (1) | CN104363894B (enExample) |
| AU (1) | AU2013246822A1 (enExample) |
| BR (1) | BR112014025507B1 (enExample) |
| CA (1) | CA2870111A1 (enExample) |
| CL (1) | CL2014002706A1 (enExample) |
| CO (1) | CO7141430A2 (enExample) |
| DK (1) | DK2836203T3 (enExample) |
| EA (1) | EA039626B1 (enExample) |
| ES (1) | ES2916803T3 (enExample) |
| GB (2) | GB201206486D0 (enExample) |
| HR (1) | HRP20220700T1 (enExample) |
| HU (1) | HUE058972T2 (enExample) |
| IL (1) | IL234862A0 (enExample) |
| IN (1) | IN2014DN08259A (enExample) |
| LT (1) | LT2836203T (enExample) |
| MX (1) | MX2014012198A (enExample) |
| PH (1) | PH12014502079A1 (enExample) |
| PL (1) | PL2836203T3 (enExample) |
| PT (1) | PT2836203T (enExample) |
| SG (1) | SG11201406251VA (enExample) |
| SI (1) | SI2836203T1 (enExample) |
| WO (1) | WO2013153221A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100255080A1 (en) * | 2009-04-02 | 2010-10-07 | Sesvalia Usa, Llc | Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment |
| MX336482B (es) | 2009-08-21 | 2016-01-21 | Henk-Andre Kroon | Formulaciones vesiculares. |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| GB201505532D0 (en) * | 2015-03-31 | 2015-05-13 | Sequessome Technology Holdings Ltd | Formulations |
| DK3316857T3 (da) | 2015-06-30 | 2021-10-18 | Sequessome Tech Holdings Limited | Multifasiske sammensætninger |
| HRP20230566T1 (hr) * | 2017-08-22 | 2023-08-18 | Moebius Medical Ltd. | Liposomalna formulacija za podmazivanje zglobova |
| JP2020534285A (ja) | 2017-09-15 | 2020-11-26 | アンパサンド バイオファーマシューティカルズ インコーポレイテッドＡｍｐｅｒｓａｎｄ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | 投与および処置の方法 |
| CN110314137B (zh) * | 2018-03-30 | 2022-04-05 | 北京泰德制药股份有限公司 | 一种含有脂质囊泡的冻干制剂 |
| KR20230041954A (ko) | 2021-09-17 | 2023-03-27 | 서울대학교산학협력단 | 골관절염 예방 또는 치료용 약학 조성물 및 건강기능식품 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4327193A (en) * | 1992-07-08 | 1994-01-31 | Dianorm-Gerate G. Maierhofer | Liposomes, method of preparing them and their use in the preparation of drugs |
| AUPN723395A0 (en) * | 1995-12-19 | 1996-01-18 | Macnaught Medical Pty Limited | Lubrication methods |
| CA2448627A1 (en) * | 2001-05-31 | 2002-12-05 | Pharmacia Corporation | Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol |
| JP2004535434A (ja) * | 2001-06-25 | 2004-11-25 | デピユイ | 関節炎にかかった関節の処置のためのグリコサミノグリカン類のリポソームカプセル化 |
| US7115666B2 (en) * | 2002-10-15 | 2006-10-03 | Renovis, Inc. | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| CN101541308B (zh) * | 2006-09-28 | 2012-02-01 | 哈达斯特医疗研究服务和开发有限公司 | 甘油磷脂用于关节润滑的用途 |
| AU2010255391C1 (en) * | 2009-06-03 | 2016-10-27 | Sequessome Technology Holdings Limited | Formulations for the treatment of deep tissue pain |
| MX336482B (es) * | 2009-08-21 | 2016-01-21 | Henk-Andre Kroon | Formulaciones vesiculares. |
| EP2340819A1 (en) * | 2009-12-23 | 2011-07-06 | Laboratorios Del. Dr. Esteve, S.A. | Compositions comprising venlafaxine and celecoxib in the treatment of pain |
| US9125786B2 (en) * | 2011-03-31 | 2015-09-08 | Phillip Anthony FEMANO | Method and device to alleviate carpal tunnel syndrome and dysfunctions of other soft tissues |
| CN105229171A (zh) * | 2013-03-13 | 2016-01-06 | 豪夫迈·罗氏有限公司 | 在人pi3kca (pik3ca)基因中检测突变的方法和组合物 |
-
2012
- 2012-04-12 GB GBGB1206486.1A patent/GB201206486D0/en not_active Ceased
-
2013
- 2013-04-12 KR KR1020147031478A patent/KR102204725B1/ko not_active Expired - Fee Related
- 2013-04-12 PT PT137159893T patent/PT2836203T/pt unknown
- 2013-04-12 HR HRP20220700TT patent/HRP20220700T1/hr unknown
- 2013-04-12 GB GB1419074.8A patent/GB2515439B/en not_active Expired - Fee Related
- 2013-04-12 SG SG11201406251VA patent/SG11201406251VA/en unknown
- 2013-04-12 PL PL13715989T patent/PL2836203T3/pl unknown
- 2013-04-12 JP JP2015504977A patent/JP2015512926A/ja active Pending
- 2013-04-12 US US14/391,754 patent/US20150065461A1/en not_active Abandoned
- 2013-04-12 DK DK13715989.3T patent/DK2836203T3/da active
- 2013-04-12 BR BR112014025507-5A patent/BR112014025507B1/pt not_active IP Right Cessation
- 2013-04-12 ES ES13715989T patent/ES2916803T3/es active Active
- 2013-04-12 IN IN8259DEN2014 patent/IN2014DN08259A/en unknown
- 2013-04-12 CA CA2870111A patent/CA2870111A1/en not_active Abandoned
- 2013-04-12 LT LTEPPCT/EP2013/057742T patent/LT2836203T/lt unknown
- 2013-04-12 MX MX2014012198A patent/MX2014012198A/es unknown
- 2013-04-12 AU AU2013246822A patent/AU2013246822A1/en not_active Abandoned
- 2013-04-12 CN CN201380031159.3A patent/CN104363894B/zh not_active Expired - Fee Related
- 2013-04-12 SI SI201331990T patent/SI2836203T1/sl unknown
- 2013-04-12 WO PCT/EP2013/057742 patent/WO2013153221A1/en not_active Ceased
- 2013-04-12 EA EA201491583A patent/EA039626B1/ru unknown
- 2013-04-12 HU HUE13715989A patent/HUE058972T2/hu unknown
- 2013-04-12 EP EP13715989.3A patent/EP2836203B1/en active Active
-
2014
- 2014-09-22 PH PH12014502079A patent/PH12014502079A1/en unknown
- 2014-09-28 IL IL234862A patent/IL234862A0/en unknown
- 2014-10-08 CL CL2014002706A patent/CL2014002706A1/es unknown
- 2014-11-12 CO CO14249925A patent/CO7141430A2/es unknown
-
2016
- 2016-11-11 US US15/349,792 patent/US20170128473A1/en not_active Abandoned
-
2021
- 2021-01-06 US US17/142,624 patent/US20210393655A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014002706A1 (es) | Formulaciones vesiculares que comprenden un fosfolipido y un agente tensoactivo y el uso en el tratamiento del dolor o movilidad reducida de una articulación. | |
| IL239923A0 (en) | Solid solution compositions and use in cardiovascular disease | |
| HRP20181169T1 (hr) | Predlijekovi fumarata i njihova upotreba u liječenju različitih bolesti | |
| BR112012031194A2 (pt) | derivados de cisteamina e seu uso no tratamento de ehna | |
| CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
| BRPI0815577A2 (pt) | Peptídeo foxm1 e agente medicinal compreendendo o mesmo. | |
| CO6480985A2 (es) | Formulaciones para el tratamiento del dolor tisular profundo | |
| CL2013001250A1 (es) | Composicion intravenosa que contiene ibuprofeno y paracetamol combinados en dosis definidas; y uso en el tratamiento del dolor y/o inflamacion. | |
| CL2015000499A1 (es) | Uso de un agente farmacéuticamente aceptable que elimina el antígeno de superficie de la hepatitis b de la sangre y un segundo agente que estimula la función inmunitaria, para tratar hepatitis b o coinfección hepatitis b/hepatitis d; y composición que comprende ambos agentes. | |
| CL2015001869A1 (es) | Composición inyectable acuosa de diclofenaco en una solucion de eter monoetilico de dietilenglicol y agua; metodo de preparacion; y uso en el tratamiento o prevencion del dolor y/o condiciones inflamatorias como dolor de cabeza, dolor de garganta, entre otras. | |
| MX2018012285A (es) | Metodos de tratamiento para enfermedades colestasicas y fibroticas. | |
| SG10201704712QA (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| MA50358A (fr) | Sémaglutide en thérapie médicale | |
| MX377510B (es) | Uso de levocetirizina y montelukast en el tratamiento de anafilaxis. | |
| CL2015001748A1 (es) | Formulaciones antiparasitarias transdermicas | |
| EA201390287A1 (ru) | Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии | |
| IL270159B (en) | Preparations containing nanometer particles for the administration of drugs for the treatment of eye diseases | |
| ZA201504783B (en) | Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent | |
| MX390899B (es) | Formulación de combinación de dosis fija, eflornitina y sulindaco. | |
| CL2010001594A1 (es) | Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida. | |
| ES2811674R1 (es) | Compuestos de ácido ascórbico y quinona en combinación con un agente antiparasitario para el tratamiento de una enfermedad parasitaria | |
| MX2016014701A (es) | (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina. | |
| CL2013002322A1 (es) | Uso de una composicion que comprende fentanilo, un intensificador de la penetracion y un liquido volatirl para preparar un medicamenti util en el tratamiento del dolor. | |
| ITUB20153104A1 (it) | Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti | |
| ECSP15005163A (es) | Composiciones líquidas orales pediátricas que contienen nepadutant |